What is BioSymetrics?

We integrate clinical insights and experimental findings using machine learning methodologies to investigate the complexities of human diseases and advance the field of precision medicine. Our pioneering Contingent AI™ technology adeptly navigates the complex interconnections within the data, resulting in valuable insights. To mitigate biases in our data, we enhance our machine learning algorithms by refining decisions made during the initial stages of data pre-processing and feature engineering. Employing zebrafish, cellular models, and a variety of phenotypic animal models, we validate in silico predictions through rigorous in vivo experimentation, complemented by genetic modifications executed both in vitro and in vivo to facilitate better translation of results. Through the application of active learning and computer vision techniques on validated models concentrating on cardiac, central nervous system, and rare diseases, we efficiently incorporate fresh data into our machine learning systems. This ongoing refinement process not only amplifies the precision of our predictions but also positions us as leaders in the evolving landscape of precision medicine research. By continuously adapting our methodologies, we ensure our work remains relevant and impactful in addressing the challenges posed by human diseases.

Integrations

No integrations listed.

Screenshots and Video

BioSymetrics Screenshot 1

Company Facts

Company Name:
BioSymetrics
Company Location:
United States
Company Website:
www.biosymetrics.com/platform

Product Details

Deployment
SaaS
Support
Web-Based Support

Product Details

Target Company Sizes
Individual
1-10
11-50
51-200
201-500
501-1000
1001-5000
5001-10000
10001+
Target Organization Types
Mid Size Business
Small Business
Enterprise
Freelance
Nonprofit
Government
Startup
Supported Languages
English

BioSymetrics Categories and Features